Kirsten Hopkins

At Bristol, International Atomic Energy Agency

Papers

2

Total Citations

75

H-Index

2

About

Dr. Kirsten Hopkins is a translational neuro-oncology researcher whose work bridges critical gaps in glioblastoma treatment and global radiotherapy access. Her primary research focuses on overcoming the blood-brain barrier (BBB) to improve chemotherapy delivery for brain tumors, particularly through convection-enhanced delivery (CED) techniques. Her most impactful work, a 2014 study on a novel implantable catheter system with transcutaneous port for intermittent CED of carboplatin in recurrent glioblastoma (73 citations), demonstrates a practical solution to the longstanding challenge of inadequate BBB penetration by systemic chemotherapies. This innovation offers a more effective, repeated-delivery approach that could significantly improve outcomes for glioblastoma patients. Dr. Hopkins has also contributed to global health equity, co-authoring a 2017 assessment of radiotherapy infrastructure and human resource capacity in South Asia, highlighting critical gaps and future needs in the region. Her work not only advances localized drug delivery strategies for aggressive brain cancers but also underscores her commitment to addressing disparities in cancer care access worldwide.

Research Focus

Key Achievements

2
H-Index
2
Papers
75
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
73 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: At Bristol, International Atomic Energy Agency

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago